What is The ICPD?
The Institute for Clinical Pharmacodynamics (ICPD) is a specialized entity dedicated to de-risking antimicrobial development. By meticulously determining optimal dosing, intervals, and durations for a range of drugs, including antibacterials, antifungals, and biologics, ICPD enhances the predictability of therapeutic outcomes. Their state-of-the-art laboratories and emphasis on translational medicine facilitate a seamless transition of drug candidates from research to patient application. The interdisciplinary team, comprising Pharm.D., Ph.D., and M.D. scientists, employs a rigorous integration of pharmacology, medicine, and statistical analysis to inform critical decision-making processes. ICPD's recognized contributions to government and corporate advisory panels underscore its pivotal role in advancing safer drug development practices.
How much funding has The ICPD raised?
The ICPD has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in The ICPD
PPP
Public-Private Partnership
What's next for The ICPD?
With a substantial $350K in total capital and a recent strategic investment of $350K, ICPD is well-positioned for accelerated growth and expanded influence in the pharmaceutical development landscape. The company's focus on reducing risk in drug development, particularly for antimicrobials, aligns with critical global health needs. Future endeavors will likely involve scaling their advanced laboratory capabilities, broadening their translational medicine initiatives, and potentially forging new strategic partnerships. This capital infusion is expected to bolster their research and development efforts, enabling them to tackle more complex drug candidates and further solidify their advisory role in the industry.
See full The ICPD company page
